HK2 and infection: As with Senexin A treatment, Senexin B inhibited the induction of HK2 during DENV2 infection, while basal expression of HK2 was unaffected (Figure 4C, right panel; DMSO mean fold change over mock: 4.64 ± 0.45, Senexin B: 3.22 ± 0.45).